CellGenix GmbH starts work on cell therapy regent facility expansion

By Gareth Macdonald contact

- Last updated on GMT

iStock/luchschen
iStock/luchschen

Related tags: Gene, Dna

CellGenix GmbH has started expanding its cell and gene therapy reagents facility in Freiburg, Germany citing the progression of customer projects into clinical development and commercial launch.

The firm will add a research and development laboratory and well as production and warehouse space at the facility. It will also install large-scale filling capacity for therapeutic recombinant proteins.

CellGenix expects the expansion project to be completed early next year. The firm also said it plans to hire staff with experience in R&D, quality control and production.

The firm cited the progression of customer projects as well as a general increase in market demand for good manufacturing practice (GMP) grade raw materials as the driver for the investment.

CEO Felicia Rosenthal said: “The investment we are making is a very positive sign for the gene and cell therapy space and the future of CellGenix. It will allow us to fulfill the increasing demand for GMP-grade cytokines and serum-free media​.”

Reagent demand

CellGenix is only the latest supplier to invest in reagent capacity citing growing demand.

In December, Thermo Fisher bought cell reagents supplier MTI-GlobalStem.

At the time Thermo told us the capacity gained will help customers “accelerate discovery in the development of disease models for drug screening, cells as factories for early development of biological drugs, and cell-based therapies.”

Related news

Show more

Related products

show more

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars